BLKB Analysis: Blackbaud: Cheap for a Reason

Executive Summary

Blackbaud reported Q4 2025 earnings on February 10, guiding FY2026 EPS of $5.15-5.25 (16-18% growth). At $47.73, the stock trades at 9.2x forward P/E — among the cheapest in the SaaS selloff cohort. Management highlighted their new Development Agent (agentic AI for nonprofit fundraising) as excluded revenue upside.

The bull case is coherent: beaten-down SaaS name with accelerating EPS growth, structural margin levers, and AI optionality at trough multiple. The bear case is stronger: CEO sold 15,000 shares at $60 in November (stock now $47.73, down 20.5%), the AI product has zero paying customers as of February 2026, organic revenue growth of 4-4.5% is bottom-quartile for SaaS, and federal funding cuts are creating real nonprofit sector stress.

Verdict: The multiple is cheap because the execution risk is high. AI revenue is immaterial (<5% upside even in optimistic scenarios), insider selling timing is dissonant, and nonprofit customers are under documented pressure from federal funding cuts. Management's guidance excludes AI revenue not because it's conservative, but because they can't model what doesn't exist yet.

Alpha: +8-22% annualized (18-month horizon to $62-82 targets), 55% conviction → 2-6% position size if entering. The risk/reward works only if you believe SaaS sector fear is peak and management can deliver on margin expansion despite organic growth deceleration.

The Setup

BLKB reported Q4 2025 earnings after market close on February 10. The stock gapped up 6.7% in after-hours trading, then reversed -7.4% the following day to close at $47.73. The intraday pattern — gap up on the beat, then reverse on guidance — suggests the Street wanted more than 4-4.5% organic growth.

The stock is down 40% over the past year, with RSI at 28 (oversold), trading at 5% of its 52-week range. Management guided:

FY2026 revenue: $1.173-1.179B (4-4.5% organic growth)
FY2026 EPS: $5.15-5.25 (16-18% growth)
FY2026 FCF: $280-290M (up 38-43% YoY)

At $47.73, BLKB trades at 9.2x forward P/E ($47.73 / $5.20 midpoint). For comparison:

Ticker	Forward P/E	1Y Return	Organic Growth
BLKB	9.2x	-40%	4-4.5%
G	8.8x	-29%	≈5%
PCTY	14x	-48%	Beat +16%
TEAM	18x	-73%	N/A
NOW	24x	-50%	21%

BLKB is tied with Genpact (G) for cheapest in the SaaS cohort. But G is horizontal IT services, while BLKB is vertical nonprofit SaaS with embedded payments. The question: Is 9.2x cheap because it's mispriced, or because the growth profile doesn't justify more?

The AI Optionality — Real or Vaporware?

CEO Mike Gianoni spent unusual time addressing "the big question" — is AI beneficial or detrimental to vertical SaaS? His answer: beneficial, and the company is shipping product.

The Development Agent is BLKB's first agentic AI product under "Agents for Good." The use case: A university with 190,000 alumni only has bandwidth to cultivate the top 10,000 donors. The Development Agent acts as additional staff, cultivating the other 180,000 via email, text, and conversational avatars. It learns from BLKB's proprietary nonprofit data, workflows, and donor personas.

Pricing: "Tens of thousands per year" per customer, multiyear subscription contracts.
Cross-sell target: "Thousands of existing customers."
Commercial availability: "Later this year" (2026).
Current paying customers: Zero disclosed as of February 10, 2026.

Gianoni on guidance:

"The new AI is not meaningfully in our current financial guidance, but offers potential upside to current expectations... We give the guide and the aspirational, and we always say plus. So that's where the plus comes from."

Translation: The Development Agent is excluded from FY2026 guidance ($1.173-1.179B revenue, $5.15-5.25 EPS) and from 5-year aspirational targets (4-6% revenue CAGR through 2030).

Materiality check:

"Tens of thousands" × "thousands of customers" = $10-50M annual revenue (back-of-envelope).
On $1.173B revenue base:

Low case: $10M = 0.9% upside
High case: $50M = 4.3% upside

Verdict: Below the 5% materiality threshold. Even if the Development Agent succeeds, it's a rounding error on FY2026-2027 financials. This is optionality, not the thesis.

The Insider Selling Problem

CEO Mike Gianoni sold 15,000 shares at $60 on November 6, 2025.

The stock closed at $47.73 on February 11, 2026.
That's a 20.5% decline in 3 months.

The timing is dissonant: Management is now guiding 16-18% EPS growth with three structural margin levers (India GCC labor arbitrage, data center closures, internal AI productivity) and excluded AI upside. Either:

The CEO doesn't believe the numbers he's presenting, or
The selling was routine/liquidity-driven and the timing was unfortunate.

The sale was $900K on a CEO comp package — not massive, but the optics are terrible. No Form 4 insider buying has occurred despite the 40% drawdown and RSI at 28. If management believed this was mispriced, why aren't they buying?

This is not a "yellow flag." It's a red flag. The CEO sold near the highs before a 20% decline while sitting on guidance he's now calling conservative. The benefit of the doubt requires ignoring the most direct signal we have: revealed preference.

The Nonprofit Sector Stress Is Real

Management's narrative: Federal funding cuts to nonprofits are actually bullish for BLKB because when grant revenue falls, nonprofits lean more on private fundraising (BLKB's platform).

Gianoni:

"When that happens, they rely on us even more because we're the platform for donations. Our software is not in the money flow of grants... When a part of their revenue line is under pressure, they put more emphasis on the other part of the revenue line, which is a Blackbaud platform."

The data contradicts this spin. According to Urban Institute research, one-third of nonprofits faced government funding disruptions in early 2025, with 21% losing funding, 27% experiencing delays/freezes, and 6% receiving stop-work orders. The FY2026 federal budget proposal calls for a 22.6% ($163B) reduction in domestic discretionary spending.

Nonprofits that experienced funding disruptions had "a less positive staffing outlook" and were "more likely to report decreasing their total number of programs, program locations, and people served" (Minneapolis Fed survey).

The 2026 outlook: "Additional funding challenges are anticipated for nonprofit organizations in 2026, which may include staffing and service cuts" (BPM LLP).

Management says they "haven't seen any customers go out of business." But the stress is documented and accelerating. COVID was a liquidity crisis; this is a structural budget retrenchment. The analogy doesn't hold.

Thesis risk: If nonprofits cut staff and programs, BLKB's per-seat and transactional revenue models both face headwinds. Saying "they'll just fundraise more" requires nonprofits to successfully offset federal cuts with private donations — an assumption, not a fact.

The Growth Problem

Organic revenue growth guided at 4-4.5% for FY2026.

That's bottom-quartile for SaaS. For context:

ServiceNow (NOW): 21% growth, trading at 24x forward
Paylocity (PCTY): Beat by 16%, trading at 14x forward
BLKB: 4-4.5% growth, trading at 9.2x forward

Management is spinning this as "steady." It's not steady — it's decelerating. FY2025 organic growth was 5.5%. The guide for FY2026 is 4-4.5%. That's a slowdown, not acceleration.

The structural margin expansion story (35.9% EBITDA margin → 40%+ by 2030) is credible. But you're paying for EPS growth derived from margin expansion and buybacks, not revenue growth. The 16-18% EPS growth guidance is:

≈4% organic revenue
≈2-3% margin expansion (operating leverage)
≈10% from share count reduction (aggressive buyback)

This works until it doesn't. When organic growth goes negative or churn accelerates, margin expansion can't save you.

The Moat Is Real, But Not Enough

BLKB has legitimate structural defenses:

1. Vertical system of record
98% recurring revenue. Nonprofits don't rip out their fundraising, donor management, and financial accounting systems lightly. Contract durations are lengthening — >20% of customers voluntarily moving from 3-year to 4-year+ terms.

2. Proprietary data
45 years of nonprofit-specific data: donor behavior, campaign benchmarks, philanthropic patterns. BLKB's AI products (AI Chat, Development Agent) are trained on "tens of petabytes" of customer data and "years of social good-centric benchmark data." Generic LLMs don't have this.

3. Embedded payments
When donations are processed through BLKB's platform, the company earns transactional revenue on top of subscription fees. Payments revenue grew 9% in 2025, above the historical 8% CAGR.

These are real moats. But moats don't guarantee growth. They defend existing revenue. The question is whether BLKB can expand in a stressed nonprofit environment or just retain what it has.

The Margin Expansion Playbook

Management outlined three structural levers to move from 35.9% EBITDA margin to 40%+ by 2030:

1. India GCC labor arbitrage
Moving from third-party contractors to direct employees in India. The Global Capability Center footprint grew "substantially" over the past 12 months and will "grow substantially" again in the next 12-18 months. Starting Q1 2026, BLKB will exclude $6-8M of transition costs from non-GAAP metrics.

2. Data center closures
Closing the last two small data centers, completing a multi-year cloud migration.

3. Internal AI productivity
In the last 4 weeks of 2025 alone, employees logged 19,000 hours of AI-assisted outcomes using Microsoft Copilot and Anthropic Claude for engineering, sales, customer success, and QA.

Gianoni: "AI is making a significant impact on our internal productivity."

The guidance assumes zero material productivity gains from internal AI. If this compounds, it flows to margin.

Credibility check: BLKB hit Rule of 40 (revenue growth % + EBITDA margin %) two years ahead of schedule. They've delivered on margin expansion before. The playbook is credible.

Risk: Labor arbitrage and cloud migration are table stakes, not differentiation. If peers are doing the same, it's necessary to compete, not a source of alpha.

Factor Decomposition

Before sizing, we need to verify how much of BLKB's 40% drawdown is company-specific vs SaaS sector compression.

Regression results (252 trading days):

Idiosyncratic variance: 88.7% ✓ (well above 75% target)
Market beta (SPY): 0.93 (slightly defensive)
Tech beta (XLK): 0.09 (minimal sector exposure)
Momentum beta (MTUM): -0.42 (negative momentum)
R² = 11.3%

Interpretation: Only 11% of BLKB's variance is explained by market/tech/momentum factors. The 40% drawdown is company-specific, not sector compression. This validates the thesis that the stock is mispriced on execution concerns, not dragged down by SaaS sector fear.

Edge audit: Do we have unusual insight in each component?

Market (16.2%): NO - but exposure is low
Tech sector (2.0%): NO - but exposure is minimal
Momentum (-7.0%): NO - negative loading actually helps (anti-momentum)
Company idio (88.7%): YES - thesis-driven insight on margin expansion, nonprofit stress, AI optionality

Total edge %: ≈89% (essentially all company-specific)

This passes the edge test. The position is appropriately sized on idiosyncratic alpha, not factor exposure.

What This Is Worth

Conservative case: 12x P/E on FY2026 EPS of $5.20 = $62.40 target (18-month horizon)

Assumes sector multiple expansion from trough 9.2x to still-discounted 12x
Raw return: 19.6% annualized
Alpha (after 4.5% risk-free): 15.1%

Optimistic case: 14x P/E on FY2027 EPS of $5.88 (13% CAGR) = $82.26 target (18-month horizon)

Assumes SaaS selloff ends, BLKB re-rates to peer median on margin expansion delivery
Raw return: 43.8% annualized
Alpha (after 4.5% risk-free): 39.3%

Conviction: 55% (medium-low)

CEO insider selling timing is dissonant
AI revenue immaterial and not launched
Nonprofit sector stress documented and accelerating
Organic growth decelerating (5.5% → 4-4.5%)

Adjusted alpha: 8.3-21.6% depending on case
Position size: 2-6% (assuming 200% total alpha across portfolio)

The Trade

BLKB at 9.2x forward with 16-18% guided EPS growth is cheap. The question is whether it's too cheap to ignore or cheap for a reason.

The bull case:

Trough multiple (9.2x) on accelerating EPS (16-18% growth)
Three credible margin expansion levers (India GCC, data centers, AI productivity)
Structural moat (vertical SaaS, embedded payments, proprietary data)
SaaS sector fear at peak, indiscriminate selloff creates opportunities
AI optionality (Development Agent) excluded from guidance

The bear case:

CEO sold at $60, stock now $47.73 (down 20.5%) — no insider buying despite 40% drawdown
AI revenue immaterial (<5% upside) with zero paying customers as of Feb 2026
Organic growth decelerating (5.5% → 4-4.5%) = bottom quartile for SaaS
Federal funding cuts creating documented nonprofit sector stress
Margin expansion is necessary to compete, not differentiation

Catalysts:

Near-term (90 days): Development Agent commercial launch with customer wins, Q1 earnings showing margin expansion
Medium-term (6-12 months): FY2026 results beating guide, AI revenue becoming material
Bear case triggers: Customer churn accelerates, transactional revenue growth <8%, Development Agent flops

Thesis breaks if: Fundamentals deteriorate (watch renewal rates, transactional revenue growth, and Development Agent adoption in next 2-3 quarters).

Verdict

This is not a "cheap SaaS moat." It's a show-me story. The multiple is cheap because execution risk is high. CEO selling at $60 before a 20% drop is a revealed preference signal. AI revenue is optionality, not the core thesis. Organic growth is slowing, not accelerating. Federal funding cuts are real, not bullish.

The trade works if you believe:

SaaS sector fear is at peak (indiscriminate selling creates mispricing)
Management can deliver margin expansion despite growth deceleration
Nonprofit sector stress doesn't translate to churn or pricing pressure
Insider selling was routine, not informed

That's a lot of "ifs." The risk/reward is 2:1 to 3:1 on an 18-month horizon ($62-82 targets from $47.73), but conviction can't be high given the contradicting evidence.

Position size: 2-6% if entering. This is a tactical trade on SaaS sector oversold conditions, not a high-conviction strategic position.

Sources: